Patriarca Francesca, Filì Carla, Geromin Antonella, Sperotto Alessandra, Prosdocimo Simonetta, Fanin Renato
Division of Hematology, Department of Bone Marrow Transplantation, Udine University Hospital, P. le S. Maria della Misericordia, I-13300 Udine, Italy.
Eur J Haematol. 2002 May;68(5):310-3. doi: 10.1034/j.1600-0609.2002.01660.x.
We describe a patient with an acute promyelocytic leukemia (APL) previously treated with two courses of cytarabin, idarubicin and all-trans retinoic acid (ATRA), who presented a medullary and meningeal relapse after 8 months of complete remission. A diagnosis of central nervous system (CNS) involvement was based on the appearance of APL blasts in the cerebrospinal fluid (CSF); magnetic resonance (MR) imaging was negative. The neurological symptoms were not evident at the time of recognition of the medullary recurrence, but appeared a few days later, when the patient had already received a reinduction treatment. When the CSF was first examined, showing atypical promyelocytes, there was no excess of blasts on bone-marrow examination. The patient was treated with ATRA and intrathecal administrations of cytoxic drugs, achieving a complete long-lasting CNS remission. The appearance of mature myeloid cells in the CSF during this treatment suggested a possible differentiating effect of ATRA towards extramedullary relapse.
我们描述了一名急性早幼粒细胞白血病(APL)患者,该患者先前接受了两个疗程的阿糖胞苷、伊达比星和全反式维甲酸(ATRA)治疗,在完全缓解8个月后出现了骨髓和脑膜复发。中枢神经系统(CNS)受累的诊断基于脑脊液(CSF)中出现APL原始细胞;磁共振(MR)成像结果为阴性。在确认骨髓复发时神经症状并不明显,但在几天后出现,此时患者已经接受了再诱导治疗。首次检查脑脊液时发现非典型早幼粒细胞,而骨髓检查时原始细胞并未增多。该患者接受了ATRA治疗及鞘内注射细胞毒性药物,实现了中枢神经系统的长期完全缓解。治疗期间脑脊液中出现成熟髓样细胞提示ATRA对髓外复发可能具有分化作用。